
Major HIV breakthrough forces hidden fragments of the virus to emerge so it can be cleared from the body
Experts could have found a way to be one step closer to curing HIV for good.
Researchers in Australia has developed a new treatment that forces hidden fragments of the virus - normally concealed within human cells - to emerge and expose themselves to the immune system.
The breakthrough could enable the body, aided by antiviral drugs, to detect and destroy any lingering viral reservoirs.
HIV has remained incurable because the virus can integrate itself into a cell's DNA, laying dormant and undetectable to both medication and immune defenses.
Scientists said they've created a nanoparticle capable of delivering genetic instructions to infected cells, prompting them to produce a signal that reveals the virus's presence.
Dr Paula Cevaal of the Doherty Institute and co-author of the study told The Guardian that the feat was 'previously thought impossible'.
Cevaal said: 'In the field of biomedicine, many things eventually don't make it into the clinic, that is the unfortunate truth; I don't want to paint a prettier picture than what is the reality.
'But in terms of specifically the field of HIV cure, we have never seen anything close to as good as what we are seeing, in terms of how well we are able to reveal this virus.
'So, from that point of view, we're very hopeful that we are also able to see this type of response in an animal, and that we could eventually do this in humans.'
The discovery was first revealed in the journal Nature Communications, where researchers said they were initially so astonished that they had to rerun the tests.
Further research would be needed to determine whether revealing the virus would be enough to trigger an immune response, with tests only being carried out in the lab.
It could still take years before clinical trials for the drug began, when it would have to go through rigorous testing before reaching consumers.
However, the advance represents another step forward for the 1.2 million Americans currently living with an HIV infection - for which they took drugs daily.
An estimated 31,800 people were believed to be infected every year, although that's a 12 per cent decline on five years ago.
Globally, nearly 40 million people have the virus.
The new nanoparticle's based on mRNA technology, the same as was used in covid vaccines made by Pfizer and other vaccine manufacturers.
In their paper, the scientists revealed that they could deliver mRNA instructions to cells using the nanoparticle. The mRNA then instruct cells to generate substances that reveal the presence of HIV, but only if the virus was present.
The study done in the laboratory was carried out in cells donated by HIV patients.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mail
44 minutes ago
- Daily Mail
The iconic landmarks set to be wiped out by The Big One... as experts raise earthquake threat level
The Hollywood sign and the Golden Gate Bridge are among the iconic landmarks set to be wiped out by a huge earthquake when 'The Big One' hits California, experts warn. The devastating seismic event is guaranteed to happen according to scientists, who are increasingly sure it will occur in the next three decades.


Daily Mail
an hour ago
- Daily Mail
Urgent warning to Bunnings shoppers over popular product sold in stores
Scientists have raised the alarm over a popular plant sold in hardware stores across Australia which could cause billions of dollars in environmental damage. The Gazania flower, an ornamental plant originally introduced to Australia between the 1950s and 1970s, is now considered highly invasive. The species poses a major threat to local ecosystems and the economy with warnings it could cost the agricultural sector up to $5billion a year. The once-decorative flower has since spread across vast areas, including grasslands, sand dunes, stream banks, roadsides, wastelands, and farmland in Western and Southern Australia. It is particularly problematic in grain crop fields in low-rainfall regions of South Australia, where farmers are struggling to control it using standard herbicides. Gazania plants and seeds are widely available for purchase across Australia, including at major retailers like Bunnings, Amazon, and online garden stores. 'There are major concerns that Gazania is killing productive land with crops unable to compete against such a vigorous weed,' researchers from LaTrobe University said. Muhammad Adnan, a PhD student at the La Trobe Institute for Sustainable Agriculture and Food (LISAF), led a study on the weed's resilience. Thousands of seeds were collected from across Australia to test how they responded to different environmental conditions. The research found the seeds could survive and germinate under a wide range of stress factors, including light and temperature extremes, salinity, moisture, and varied burial depths. 'It suggests they could become a problematic weed year-round in many parts of Australia, potentially leading to high infestation levels,' Mr Adnan said. The Invasive Species Council has called for a nationwide ban on the sale of Gazania. 'Gazanias are not only overrunning native grasslands, coastlines and roadsides, they are moving into grain production areas, choking out crops and costing farmers,' Invasive Species Council Advocacy Manager Imogen Ebsworth said. In a statement to Daily Mail Australia, Bunnings said its sale of the flower complies with all relevant regulations. 'Like many nurseries and retailers, we sell a wide range of locally-sourced plants across our stores and we work hard to create an assortment that caters to customer preferences and demand,' a spokesperson said. 'As always, we closely follow all relevant local biosecurity regulations and the advice of regulators about the plants we sell.' The Victorian Government has officially listed Gazania as a highly invasive species, and South Australia banned the plant altogether in March 2021.


Sky News
5 hours ago
- Sky News
Blood test for Alzheimer's disease is highly accurate, researchers say
Researchers say a new blood test for Alzheimer's disease has been shown to be highly accurate in detecting people with early symptoms. Scientists looked for two proteins - amyloid beta 42/40 and p-tau217 - and found the test was 95% accurate in identifying patients with existing cognitive impairment linked to the condition. The US study involved 509 patients in an outpatient memory clinic in Florida and was published in the medical journal Alzheimer's and Dementia. The test, which has already been approved by the US regulator, was also 82% accurate for specificity, which means it could rule out people without dementia. Dr Gregg Day, who led the study, said the test was as good as existing, but more invasive, tests. He said the next step was to extend the test to a wider range of patients, including those with early Alzheimer's who do not have any cognitive symptoms. Scientists say the two proteins, which they have identified in blood plasma, are associated with the buildup of amyloid plaques. Amyloid protein can be found in our brains, but in Alzheimer's disease, amyloid sticks together and forms abnormal deposits, which are thought to be toxic to brain cells. Dr Richard Oakley, associate director for research and innovation at the Alzheimer's Society in the UK, said the results "suggest this test is very accurate". "Blood tests will be critical to accelerate diagnosis and give more people access to the care, support and treatments they desperately need faster than ever before," he added. In the UK, the Blood Biomarker Challenge is a multi-million-pound research programme supported by the Alzheimer's Society, Alzheimer's Research UK and the National Institute for Health and Care Research. 1:09 Its goal is to bring blood tests for dementia diagnosis to the NHS by 2029. Dr Julia Dudley, head of research at Alzheimer's Research UK, said: "We urgently need to improve how we diagnose dementia and it's great to see international research working towards this goal." She said the studies like the Blood Biomarker Challenge are a "crucial part of making diagnosis easier and faster, which will bring us closer to a cure". "The study is testing blood tests, including p-tau217, in thousands of people from sites across the UK," she added.